Treatment of Genitourinary Syndrome of Menopause in Breast Cancer and Gynecologic Cancer Survivors: Retrospective Analysis of Efficacy and Safety of Vaginal Estriol, Vaginal Dehydroepiandrosterone and Ospemifene
Ermelinda Pennacchini, Roberta Dall'Alba, Silvia Iapaolo, Matilde Marinelli, Pier Luigi Palazzetti, Marzio Angelo Zullo, Mauro Cervigni, Andrea Morciano, Lorenzo Campanella, Benedetto Ferraresi, Michele Carlo Schiavi · 2024
Read Treatment of Genitourinary Syndrome of Menopause in Breast Cancer and Gynecologic Cancer Survivors: Retrospective Analysis of Efficacy and Safety of Vaginal Estriol, Vaginal Dehydroepiandrosterone and Ospemifene by Ermelinda Pennacchini, Roberta Dall'Alba, Silvia Iapaolo, Matilde Marinelli, Pier Luigi Palazzetti, Marzio Angelo Zullo, Mauro Cervigni, Andrea Morciano, Lorenzo Campanella, Benedetto Ferraresi, Michele Carlo Schiavi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11745731.txt.
Description
Ermelinda Pennacchini and co-authors compare menopause symptom treatments in cancer survivors in a 2024 study. Genitourinary symptoms trouble many women after menopause. Hormone caution runs high after breast or gynecologic cancer. Three gentler options are used in practice anyway.
One hundred eighty-five survivors were analyzed retrospectively by treatment. Groups received a vaginal hormone cream, a precursor cream, or a tablet drug. Six months of follow-up tracked safety and relief. Validated questionnaires measured sexual function and distress. Pain scales and quality-of-life surveys joined the battery. No uterine thickening or cancer recurrence appeared anywhere. Sexual activity rates rose significantly in all groups. Function scores improved across every arm. Symptom complaints fell in parallel. The authors present all three as viable options. Survivor clinics gain comparative reassurance. Prospective trials would firm up the ranking.
Catalog record
| CREATOR | Ermelinda Pennacchini, Roberta Dall'Alba, Silvia Iapaolo, Matilde Marinelli, Pier Luigi Palazzetti, Marzio Angelo Zullo, Mauro Cervigni, Andrea Morciano, Lorenzo Campanella, Benedetto Ferraresi, Michele Carlo Schiavi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |